Pharmaniaga Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,928	3,759	3,404	3,481	4,815
Revenue Growth (YoY)	4.48%	10.43%	-2.20%	-27.71%	76.69%
Cost of Revenue	3,519	3,219	3,097	3,138	4,185
Gross Profit	409.16	540.49	307.82	342.72	630.02
Selling, General & Admin	279.51	251.96	299.58	292.6	301.56
Amortization of Goodwill & Intangibles	-	4.07	5.64	5.17	3.61
Operating Expenses	279.51	279.57	328.27	314.72	322.64
Operating Income	129.65	260.93	-20.45	28	307.37
Interest Expense	-61.35	-71.97	-61.84	-40.04	-33.32
Interest & Investment Income	5.66	2.25	1.48	0.91	1.52
Currency Exchange Gain (Loss)	-	-	1.13	0.04	0.93
Other Non Operating Income (Expenses)	0.78	2.89	0.66	3.03	0.51
EBT Excluding Unusual Items	74.74	194.1	-79.03	-8.06	277
Impairment of Goodwill	-	-	-	-50.27	-
Gain (Loss) on Sale of Assets	-	0.08	0.86	0.05	0.07
Asset Writedown	-	-	-	-552.31	-
Pretax Income	74.74	194.18	-78.16	-610.59	277.08
Income Tax Expense	24.05	60.39	0.58	17.07	104.87
Earnings From Continuing Operations	50.68	133.79	-78.74	-627.65	172.21
Minority Interest in Earnings	-2.17	-1.97	-1.42	-2.27	-0.06
Net Income	48.51	131.82	-80.16	-629.92	172.15
Net Income to Common	48.51	131.82	-80.16	-629.92	172.15
Net Income Growth	-63.20%	-	-	-	526.25%
Shares Outstanding (Basic)	3,614	1,441	1,368	1,310	1,309
Shares Outstanding (Diluted)	3,614	1,441	1,368	1,310	1,309
Shares Change (YoY)	150.74%	5.38%	4.40%	0.05%	0.04%
EPS (Basic)	0.01	0.09	-0.06	-0.48	0.13
EPS (Diluted)	0.01	0.09	-0.06	-0.48	0.13
EPS Growth	-85.35%	-	-	-	526.09%
Free Cash Flow	-47.47	11.51	-3.72	-201.6	-94.44
Free Cash Flow Per Share	-0.01	0.01	-0.00	-0.15	-0.07
Dividend Per Share	-	-	-	0.019	0.093
Dividend Growth	-	-	-	-79.57%	322.73%
Gross Margin	10.42%	14.38%	9.04%	9.85%	13.08%
Operating Margin	3.30%	6.94%	-0.60%	0.80%	6.38%
Profit Margin	1.23%	3.51%	-2.35%	-18.10%	3.57%
Free Cash Flow Margin	-1.21%	0.31%	-0.11%	-5.79%	-1.96%
EBITDA	156.83	288.49	7.35	55.62	335.28
EBITDA Margin	3.99%	7.67%	0.22%	1.60%	6.96%
D&A For EBITDA	27.18	27.57	27.79	27.62	27.9
EBIT	129.65	260.93	-20.45	28	307.37
EBIT Margin	3.30%	6.94%	-0.60%	0.80%	6.38%
Effective Tax Rate	32.18%	31.10%	-	-	37.85%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.